PharmaResources (China) Today
| 301230 Stock | 27.00 0.62 2.24% |
Performance11 of 100
| Odds Of DistressOver 58
|
PharmaResources is trading at 27.00 as of the 18th of December 2024, a 2.24% down since the beginning of the trading day. The stock's open price was 27.62. PharmaResources has over 58 % chance of experiencing financial distress in the next 2 years of operation, but had a somewhat good returns during the last 90 days. The performance scores are derived for the period starting the 24th of December 2023 and ending today, the 18th of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
PharmaResources is entity of China. It is traded as Stock on SHE exchange. The company has 139.59 M outstanding shares. More on PharmaResources Co Ltd
Moving together with PharmaResources Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
PharmaResources Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. PharmaResources' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding PharmaResources or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Health Care (View all Sectors) |
PharmaResources Co Ltd (301230) is traded on Shenzhen Stock Exchange in China and employs 1,047 people. PharmaResources is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.77 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PharmaResources's market, we take the total number of its shares issued and multiply it by PharmaResources's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. PharmaResources operates under Biotechnology sector and is part of Health Care industry. The entity has 139.59 M outstanding shares.
Check PharmaResources Probability Of Bankruptcy
Ownership AllocationPharmaResources owns a total of 139.59 Million outstanding shares. PharmaResources has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check PharmaResources Ownership Details
PharmaResources Risk Profiles
Although PharmaResources' alpha and beta are two of the key measurements used to evaluate PharmaResources' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.15 | |||
| Semi Deviation | 4.39 | |||
| Standard Deviation | 4.76 | |||
| Variance | 22.7 |
PharmaResources Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in PharmaResources without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
| All Next | Launch Module |
PharmaResources Corporate Executives
Elected by the shareholders, the PharmaResources' board of directors comprises two types of representatives: PharmaResources inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PharmaResources. The board's role is to monitor PharmaResources' management team and ensure that shareholders' interests are well served. PharmaResources' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PharmaResources' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hongjian Zhang | CoFounder Officer | Profile | |
| Ping Chen | GM, CoFounder | Profile |
Other Information on Investing in PharmaResources Stock
PharmaResources financial ratios help investors to determine whether PharmaResources Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PharmaResources with respect to the benefits of owning PharmaResources security.